PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

Robert M. Hughes, DO - Retinal Disease in the ED: “See Me Now”- A Primer for Emergency Physicians on the Recognition and Differential Diagnosis of Retinal Vein Occlusions

12.19.2023 - By PVI, PeerView Institute for Medical EducationPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/FHQ865. CME credit will be available until December 15, 2024. Retinal Disease in the ED: “See Me Now”- A Primer for Emergency Physicians on the Recognition and Differential Diagnosis of Retinal Vein Occlusions This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Emergency Physicians and PVI, PeerView Institute for Medical Education. The American College of Emergency Physicians is accredited by the ACCME to provide continuing medical education for physicians. This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education. SupportThis activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. DisclosuresRobert M. Hughes, DO, has no financial interests/relationships or affiliations in relation to this activity. Christina Y. Weng, MD, MBA, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Alcon; Allergan/AbbVie Inc.; Alimera Sciences; Apellis Pharmaceuticals; Dutch Ophthalmic Research Center (DORC); EyePoint Pharmaceuticals, Inc.; Genentech, Inc.; IVERIC bio, Inc.; Novartis Pharmaceuticals Corporation; Regeneron Pharmaceuticals Inc.; and REGENXBIO.Grant/Research Support from AGTC; Alimera Sciences; and DRCR Retina Network.Other Financial or Material Support in the form of royalties from Springer Publishers. Medical DirectorKristin Tomlinson, PhD, has no financial interests/relationships or affiliations in relation to this activity.

More episodes from PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast